Literature DB >> 17481460

A synthesis review of exemplary drug abuse prevention programs in the United States.

Ken C Winters1, Tanya Fawkes, Tamara Fahnhorst, Andria Botzet, Gerald August.   

Abstract

In the United States, there has been a concerted emphasis during the past 30 years toward identifying and implementing evidence-based drug prevention programs. The wealth of prevention efficacy research has contributed to the publication of several recent reports on promising, model, and effective programs. We identified five such recent reports, four from the federal government and one from a private foundation, that had nominated and described 100 exemplary prevention programs. Of these 100 programs, 70 reported on evidence of effectiveness. We conducted a qualitative analysis on these 70 exemplary programs. Based on a systematic review process, we identified 10 elements that were characteristic of most (at least 75%) of the programs. These 10 elements are described and discussed in light of public policy issues.

Entities:  

Mesh:

Year:  2006        PMID: 17481460     DOI: 10.1016/j.jsat.2006.10.002

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  11 in total

1.  Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

2.  Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age.

Authors:  Ken C Winters; Chih-Yuan S Lee
Journal:  Drug Alcohol Depend       Date:  2007-09-20       Impact factor: 4.492

3.  Synthetic and Other Drug Use among High School Students: The Role of Perceived Prevalence, Access, and Harms.

Authors:  Katrina J Debnam; Shonali Saha; Catherine P Bradshaw
Journal:  Subst Use Misuse       Date:  2018-04-06       Impact factor: 2.164

4.  Peer attitudes effects on adolescent substance use: the moderating role of race and gender.

Authors:  Michael J Mason; Jeremy Mennis; Julie Linker; Cristina Bares; Nikola Zaharakis
Journal:  Prev Sci       Date:  2014-02

5.  Developing Community Reinforcement and Family Training (CRAFT) for Parents of Treatment-Resistant Adolescents.

Authors:  Kimberly C Kirby; Brian Versek; MaryLouise E Kerwin; Kathleen Meyers; Lois A Benishek; Elena Bresani; Yukiko Washio; Amelia Arria; Robert J Meyers
Journal:  J Child Adolesc Subst Abuse       Date:  2015-05-04

6.  Mediation effects of a culturally generic substance use prevention program for Asian American adolescents.

Authors:  Lin Fang; Steven P Schinke
Journal:  Asian Am J Psychol       Date:  2014-06-01

7.  Risk-Taking Propensity Changes Throughout the Course of Residential Substance Abuse Treatment.

Authors:  Will M Aklin; Matthew T Tull; Christopher W Kahler; C W Lejuez
Journal:  Pers Individ Dif       Date:  2009-03-01

8.  Improving targets for the prevention of drug use disorders: sociodemographic predictors of transitions across drug use stages in the national comorbidity survey replication.

Authors:  Joel Swendsen; James C Anthony; Kevin P Conway; Louisa Degenhardt; Lisa Dierker; Meyer Glantz; Jianping He; Amanda Kalaydjian; Ronald C Kessler; Nancy Sampson; Kathleen R Merikangas
Journal:  Prev Med       Date:  2008-09-26       Impact factor: 4.018

9.  Socio-demographic risk factors for alcohol and drug dependence: the 10-year follow-up of the national comorbidity survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Lisa Dierker; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2009-06-22       Impact factor: 6.526

10.  The NARCONON drug education curriculum for high school students: a non-randomized, controlled prevention trial.

Authors:  Richard D Lennox; Marie A Cecchini
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.